Detection of prions in the plasma of presymptomatic and symptomatic patients with variant Creutzfeldt-Jakob disease

Science Translational Medicine

Volumn 8, Issue 370, 2016, Pages

  Bougard, Daisy ^a   Brandel, Jean Philippe ^b,c,d   Bélondrade, Maxime ^a   Béringue, Vincent ^e   Segarra, Christiane ^a   Fleury, Hervé ^f   Laplanche, Jean Louis ^d,g   Mayran, Charly ^a   Nicot, Simon ^a   Green, Alison ^h   Welaratne, Arlette ^c   Narbey, David ⁱ   Fournier Wirth, Chantal ^a   Knight, Richard ^h   Will, Robert ^h   Tiberghien, Pierre ^i,j   Haïk, Stéphane ^b,c,d   Coste, Joliette ^a,i  

^a UNIV MONTPELLIER   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^d Centre National de Référence des Agents Transmissibles Non Conventionnels   (France)

^e INRA Institut National de la Recherche Agronomique   (France)

^f HÔPITAL PELLEGRIN   (France)

^g HÔPITAL LARIBOISIÈRE   (France)

^h UNIVERSITY OF EDINBURGH   (United Kingdom)

ⁱ ETABLISSEMENT FRANÇAIS DU SANG   (France)

^j UNIVERSITÉ DE FRANCHE COMTÉ   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN;

AGED; ARTICLE; ASSAY; ASYMPTOMATIC DISEASE; CONTROLLED STUDY; CROSS REACTION; GENE AMPLIFICATION; HUMAN; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; PLASMINOGEN BEAD CAPTURE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN MISFOLDING; PROTEIN MISFOLDING CYCLIC AMPLIFICATION; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS; VARIANT CREUTZFELDT JAKOB DISEASE; BLOOD; BLOOD EXAMINATION; CREUTZFELDT JAKOB DISEASE; FRANCE; PROCEDURES; REPRODUCIBILITY; TREATMENT OUTCOME; UNITED KINGDOM;

CREUTZFELDT-JAKOB SYNDROME; FRANCE; HEMATOLOGIC TESTS; HUMANS; PRION PROTEINS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME; UNITED KINGDOM;

EID: 85006964744     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.aag1257     Document Type: Article

References (50)

1. M. E. Bruce, R. G. Will, J. W. Ironside, I. McConnell, D. Drummond, A. Suttie, L. McCardle, A. Chree, J. Hope, C. Birkett, S. Cousens, H. Fraser, C. J. Bostock, Transmissions to mice indicate that 'new variant' CJD is caused by the BSE agent. Nature 389, 498-501 (1997).
2. R. G. Will, J. W. Ironside, M. Zeidler, S. N. Cousens, K. Estibeiro, A. Alperovitch, S. Poser, M. Pocchiari, A. Hofman, P. G. Smith, A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347, 921-925 (1996).
3. J.-P. Brandel, C. A. Heath, M. W. Head, E. Levavasseur, R. Knight, J.-L. Laplanche, J. P. M. Langeveld, J. W. Ironside, J.-J. Hauw, J. Mackenzie, A. Alpérovitch, R. G. Will, S. Haïk, Variant Creutzfeldt-Jakob disease in France and the United Kingdom: Evidence for the same agent strain. Ann. Neurol. 65, 249-256 (2009).
4. National Creutzfeldt-Jakob Disease Research and Surveillance Unit, Variant Creutzfeldt-Jakob Disease Cases Worldwide (2016); www.cjd.ed.ac.uk/documents/worldfigs.pdf.
5. A. F. Hill, R. J. Butterworth, S. Joiner, G. Jackson, M. N. Rossor, D. J. Thomas, A. Frosh, N. Tolley, J. E. Bell, M. Spencer, A. King, S. Al-Sarraj, J. W. Ironside, P. L. Lantos, J. Collinge, Investigation of variant Creutzfeldt-Jakob disease and other human prion diseases with tonsil biopsy samples. Lancet 353, 183-189 (1999).
6. J. D. F. Wadsworth, S. Joiner, A. F. Hill, T. A. Campbell, M. Desbruslais, P. J. Luthert, J. Collinge, Tissue distribution of protease resistant prion protein in variant Creutzfeldt-Jakob disease using a highly sensitive immunoblotting assay. Lancet 358, 171-180 (2001).
7. O. Andréoletti, C. Litaise, H. Simmons, F. Corbière, S. Lugan, P. Costes, F. Schelcher, D. Vilette, J. Grassi, C. Lacroux, Highly efficient prion transmission by blood transfusion. PLOS Pathog. 8, e1002782 (2012).
8. N. Bons, S. Lehmann, N. Mestre-Francès, D. Dormont, P. Brown, Brain and buffy coat transmission of bovine spongiform encephalopathy to the primate Microcebus murinus. Transfusion 42, 513-516 (2002).
9. F. Houston, J. D. Foster, A. Chong, N. Hunter, C. J. Bostock, Transmission of BSE by blood transfusion in sheep. Lancet 356, 999-1000 (2000).
10. C. Lacroux, D. Bougard, C. Litaise, H. Simmons, F. Corbiere, D. Dernis, R. Tardivel, N. Morel, S. Simon, S. Lugan, P. Costes, J. L. Weisbecker, F. Schelcher, J. Grassi, J. Coste, O. Andréoletti, Impact of leucocyte depletion and prion reduction filters on TSE blood borne transmission. PLOS ONE 7, e42019 (2012).
11. C. A. Llewelyn, P. E. Hewitt, R. S. G. Knight, K. Amar, S. Cousens, J. Mackenzie, R. G. Will, Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 363, 417-421 (2004).
12. A. H. Peden, M. W. Head, D. L. Ritchie, J. E. Bell, J. W. Ironside, Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364, 527-529 (2004).
13. S. J. Wroe, S. Pal, D. Siddique, H. Hyare, R. Macfarlane, S. Joiner, J. M. Linehan, S. Brandner, J. D. F. Wadsworth, P. Hewitt, J. Collinge, Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: A case report. Lancet 368, 2061-2067 (2006).
14. A. Peden, L. McCardle, M. W. Head, S. Love, H. J. T. Ward, S. N. Cousens, D. M. Keeling, C. M. Millar, F. G. H. Hill, J. W. Ironside, Variant CJD infection in the spleen of a neurologically asymptomatic UK adult patient with haemophilia. Haemophilia 16, 296-304 (2010).
15. K. Holada, J. G. Vostal, P. W. Theisen, C. MacAuley, L. Gregori, R. G. Rohwer, Scrapie infectivity in hamster blood is not associated with platelets. J. Virol. 76, 4649-4650 (2002).
16. O. N. Gill, Y. Spencer, A. Richard-Loendt, C. Kelly, R. Dabaghian, L. Boyes, J. Linehan, M. Simmons, P. Webb, P. Bellerby, N. Andrews, D. A. Hilton, J. W. Ironside, J. Beck, M. Poulter, S. Mead, S. Brandner, Prevalent abnormal prion protein in human appendixes after bovine spongiform encephalopathy epizootic: Large scale survey. BMJ 347, f5675 (2013).
17. D. A. Hilton, A. C. Ghani, L. Conyers, P. Edwards, L. McCardle, D. Ritchie, M. Penney, D. Hegazy, J. W. Ironside, Prevalence of lymphoreticular prion protein accumulation in UK tissue samples. J. Pathol. 203, 733-739 (2004).
18. J. A. Edgeworth, M. Farmer, A. Sicilia, P. Tavares, J. Beck, T. Campbell, J. Lowe, S. Mead, P. Rudge, J. Collinge, G. S. Jackson, Detection of prion infection in variant Creutzfeldt-Jakob disease: A blood-based assay. Lancet 377, 487-493 (2011).
19. G. S. Jackson, J. Burk-Rafel, J. A. Edgeworth, A. Sicilia, S. Abdilahi, J. Korteweg, J. Mackey, C. Thomas, G. Wang, S. Mead, J. Collinge, A highly specific blood test for vCJD. Blood 123, 452-453 (2014).
20. G. S. Jackson, J. Burk-Rafel, J. A. Edgeworth, A. Sicilia, S. Abdilahi, J. Korteweg, J. Mackey, C. Thomas, G. Wang, J. M. Schott, C. Mummery, P. F. Chinnery, S. Mead, J. Collinge, Population screening for variant Creutzfeldt-Jakob disease using a novel blood test: Diagnostic accuracy and feasibility study. JAMA Neurol. 71, 421-428 (2014).
21. C. Lacroux, E. Comoy, M. Moudjou, A. Perret-Liaudet, S. Lugan, C. Litaise, H. Simmons, C. Jas-Duval, I. Lantier, V. Béringue, M. Groschup, G. Fichet, P. Costes, N. Streichenberger, F. Lantier, J. P. Deslys, D. Vilette, O. Andréoletti, Preclinical detection of variant CJD and BSE prions in blood. PLOS Pathog. 10, e1004202 (2014).
22. C. D. Orrú, J. M. Wilham, L. D. Raymond, F. Kuhn, B. Schroeder, A. J. Raeber, B. Caughey, Prion disease blood test using immunoprecipitation and improved quaking-induced conversion. MBio 2, e00078-11 (2011).
23. P. Saá, J. Castilla, C. Soto, Presymptomatic detection of prions in blood. Science 313, 92-94 (2006).
24. F. Moda, P. Gambetti, S. Notari, L. Concha-Marambio, M. Catania, K.-W. Park, E. Maderna, S. Suardi, S. Haïk, J.-P. Brandel, J. Ironside, R. Knight, F. Tagliavini, C. Soto, Prions in the urine of patients with variant Creutzfeldt-Jakob disease. N. Engl. J. Med. 371, 530-539 (2014).
25. European Commission, Technical specifications for in vitro diagnostic medical devices (Official Journal of the European Union, 2011).
26. G. P. Saborio, B. Permanne, C. Soto, Sensitive detection of pathological prion protein by cyclic amplification of protein misfolding. Nature 411, 810-813 (2001).
27. M. B. Fischer, C. Roeckl, P. Parizek, H. P. Schwarz, A. Aguzzi, Binding of disease-associated prion protein to plasminogen. Nature 408, 479-483 (2000).
28. M. Maissen, C. Roeckl, M. Glatzel, W. Goldmann, A. Aguzzi, Plasminogen binds to disease-associated prion protein of multiple species. Lancet 357, 2026-2028 (2001).
29. C. E. Mays, C. Ryou, Plasminogen stimulates propagation of protease-resistant prion protein in vitro. FASEB J. 24, 5102-5112 (2010).
30. C. Segarra, D. Bougard, M. Moudjou, H. Laude, V. Béringue, J. Coste, Plasminogen-based capture combined with amplification technology for the detection of PrPTSE in the pre-clinical phase of infection. PLOS ONE 8, e69632 (2013).
31. L. Concha-Marambio, S. Pritzkow, F. Moda, F. Tagliavini, J. Ironside, P. Schulz, C. Soto, Detection of prions in blood from patients with variant Creutzfeldt-Jakob disease. Sci. Transl. Med. 8, 370ra183 (2016).
32. J. Y. Douet, S. Zafar, A. Perret-Liaudet, C. Lacroux, S. Lugan, N. Aron, H. Cassard, C. Ponto, F. Corbière, J. M. Torres, I. Zerr, O. Andreoletti, Detection of infectivity in blood of persons with variant and sporadic Creutzfeldt-Jakob disease. Emerg. Infect. Dis. 20, 114-117 (2014).
33. R. Atarashi, J. M. Wilham, L. Christensen, A. G. Hughson, R. A. Moore, L. M. Johnson, H. A. Onwubiko, S. A. Priola, B. Caughey, Simplified ultrasensitive prion detection by recombinant PrP conversion with shaking. Nat. Methods 5, 211-212 (2008).
34. J. M. Wilham, C. D. Orrú, R. A. Bessen, R. Atarashi, K. Sano, B. Race, K. D. Meade-White, L. M. Taubner, A. Timmes, B. Caughey, Rapid end-point quantitation of prion seeding activity with sensitivity comparable to bioassays. PLOS Pathog. 6, e1001217 (2010).
35. R. Atarashi, K. Satoh, K. Sano, T. Fuse, N. Yamaguchi, D. Ishibashi, T. Matsubara, T. Nakagaki, H. Yamanaka, S. Shirabe, M. Yamada, H. Mizusawa, T. Kitamoto, G. Klug, A. McGlade, S. J. Collins, N. Nishida, Ultrasensitive human prion detection in cerebrospinal fluid by real-time quaking-induced conversion. Nat. Med. 17, 175-178 (2011).
36. L. I. McGuire, A. H. Peden, C. D. Orrú, J. M. Wilham, N. E. Appleford, G. Mallinson, M. Andrews, M. W. Head, B. Caughey, R. G. Will, R. S. G. Knight, A. J. E. Green, Real time quaking-induced conversion analysis of cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease. Ann. Neurol. 72, 278-285 (2012).
37. C. D. Orrú, M. Bongianni, G. Tonoli, S. Ferrari, A. G. Hughson, B. R. Groveman, M. Fiorini, M. Pocchiari, S. Monaco, B. Caughey, G. Zanusso, A test for Creutzfeldt-Jakob disease using nasal brushings. N. Engl. J. Med. 371, 519-529 (2014).
38. A. H. Peden, L. I. McGuire, N. E. J. Appleford, G. Mallinson, J. M. Wilham, C. D. Orrú, B. Caughey, J. W. Ironside, R. S. Knight, R. G. Will, A. J. E. Green, M. W. Head, Sensitive and specific detection of sporadic Creutzfeldt-Jakob disease brain prion protein using real-time quaking-induced conversion. J. Gen. Virol. 93, 438-449 (2012).
39. M. Gillies, G. Chohan, C. A. Llewelyn, J. MacKenzie, H. J. T. Ward, P. E. Hewitt, R. G. Will, A retrospective case note review of deceased recipients of vCJD-implicated blood transfusions. Vox Sang. 97, 211-218 (2009).
40. S. Mead, J. D. F. Wadsworth, M.-C. Porter, J. M. Linehan, W. Pietkiewicz, G. S. Jackson, S. Brandner, J. Collinge, Variant Creutzfeldt-Jakob disease with extremely low lymphoreticular deposition of prion protein. JAMA Neurol. 71, 340-343 (2014).
41. B. Chen, R. Morales, M. A. Barria, C. Soto, Estimating prion concentration in fluids and tissues by quantitative PMCA. Nat. Methods 7, 519-520 (2010).
42. S. el Tawil, G. Mackay, L. Davidson, D. Summers, R. Knight, R. Will, Variant Creutzfeldt-Jakob disease in older patients. J. Neurol. Neurosurg. Psychiatry 86, 1279-1280 (2015).
43. J. P. Brandel, A. Welaratne, D. Salomon, I. Capek, V. Vaillant, A. Aouba, S. Haïk, A. Alpérovitch, Can mortality data provide reliable indicators for Creutzfeldt-Jakob disease surveillance? A study in France from 2000 to 2008. Neuroepidemiology 37, 188-192 (2011).
44. M. Zeildler, C. Gibbs, F. Meslin, WHO manual for strenthening diagnosis and surveillance of Creutzfeldt-Jakob disease. (1998).
45. I. Zerr, K. Kallenberg, D. M. Summers, C. Romero, A. Taratuto, U. Heinemann, M. Breithaupt, D. Varges, B. Meissner, A. Ladogana, M. Schuur, S. Haik, S. J. Collins, G. H. Jansen, G. B. Stokin, J. Pimentel, E. Hewer, D. Collie, P. Smith, H. Roberts, J. P. Brandel, C. van Duijn, M. Pocchiari, C. Begue, P. Cras, R. G. Will, P. Sanchez-Juan, Updated clinical diagnostic criteria for sporadic Creutzfeldt-Jakob disease. Brain 132, 2659-2668 (2009).
46. V. Béringue, A. Le Dur, P. Tixador, F. Reine, L. Lepourry, A. Perret-Liaudet, S. Haïk, J.-L. Vilotte, M. Fontés, H. Laude, Prominent and persistent extraneural infection in human PrP transgenic mice infected with variant CJD. PLOS ONE 3, e1419 (2008).
47. C. Segarra, S. Lehmann, J. Coste, Prion protein expression and processing in human mononuclear cells: The impact of the codon 129 prion gene polymorphism. PLOS ONE 4, e5796 (2009).
48. C. J. Clopper, E. S. Pearson, The use of confidence or fiducial limits illustrated in the case of the binomial. Biometrika 26, 404-413 (1934).
49. R. C. Team, R: A language and environment for statistical computing. (2014).
50. K. Peoc'h, P. Manivet, P. Beaudry, F. Attane, G. Besson, D. Hannequin, N. Delasnerie-Lauprêtre, J.-L. Laplanche, Identification of three novel mutations (E196K, V203I, E211Q) in the prion protein gene (PRNP) in inherited prion diseases with Creutzfeldt-Jakob disease phenotype. Hum. Mutat. 15, 482 (2000).